| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |